CORT
CORCEPT THERAPEUTICS INC
Company overview
- Market capitalization
- $12.50B
- Employees
- 730
- Latest publication
- 2026-09-29
About CORCEPT THERAPEUTICS INC
Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States. The company offers Korlym, an oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. It also develops relacorilant, a selective cortisol modulator for patients with hypercortisolism; a selective cortisol modulator miricorilant, which is in Phase 1b trial for metabolic dysfunction-associated steatohepatitis; and a portfolio of proprietary selective cortisol modulators, such as relacorilant, nenocorilant, miricorilant, and dazucorilant for the treatment of Lou Gehrig's disease. The company was incorporated in 1998 and is headquartered in Redwood City, California.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 256,147,000USD | 202,125,000USD | 207,638,000USD | 194,430,000USD | 157,214,000USD | 181,890,000USD | 182,546,000USD | 163,796,000USD |
| Cost Of Revenue | 4,061,000USD | 2,545,000USD | 4,596,000USD | 3,433,000USD | 2,403,000USD | 2,956,000USD | 2,867,000USD | 2,524,000USD |
| Gross Profit | 252,086,000USD | 199,580,000USD | 203,042,000USD | 190,997,000USD | 154,811,000USD | 178,934,000USD | 179,679,000USD | 161,272,000USD |
| Research Development | 53,890,000USD | 64,855,999USD | 68,846,000USD | 60,471,000USD | 60,735,000USD | 70,300,000USD | 59,336,000USD | 58,745,000USD |
| Selling General Administrative | 156,896,000USD | 130,237,000USD | 123,977,000USD | 103,851,000USD | 90,660,000USD | 83,372,000USD | 73,745,000USD | 66,935,000USD |
| Total Operating Expenses | 210,786,000USD | 195,093,000USD | 192,823,000USD | 164,322,000USD | 151,395,000USD | 153,672,000USD | 133,081,000USD | 125,680,000USD |
| Operating Income | 41,300,000USD | 4,487,000USD | 10,219,000USD | 26,675,000USD | 3,416,000USD | 25,262,000USD | 46,598,000USD | 35,592,000USD |
| Total Other Income Expense Net | 4,631,000USD | 5,423,000USD | 5,024,000USD | 5,017,000USD | 6,202,000USD | 6,698,000USD | 6,345,000USD | 6,004,000USD |
| Income Before Tax | 45,931,000USD | 9,910,000USD | 15,243,000USD | 31,692,000USD | 9,618,000USD | 31,960,000USD | 52,943,000USD | 41,596,000USD |
| Income Tax Expense | 2,944,000USD | -14,378,000USD | -4,425,000USD | -3,457,000USD | -10,929,000USD | 1,214,000USD | 5,730,000USD | 6,108,000USD |
| Net Income | 42,987,000USD | 24,288,000USD | 19,668,000USD | 35,149,000USD | 20,547,000USD | 30,389,000USD | 46,690,000USD | 35,488,000USD |
| Net Income Applicable To Common Shares | 42,141,000USD | — | — | — | — | — | — | — |
| Interest Income | — | 5,423,000USD | 5,024,000USD | 5,017,000USD | 6,202,000USD | 6,698,000USD | 6,345,000USD | 6,004,000USD |
| Net Interest Income | — | 5,423,000USD | 5,024,000USD | 5,017,000USD | 6,202,000USD | 6,698,000USD | 6,345,000USD | 6,004,000USD |
| Tax Provision | — | -14,378,000USD | -4,425,000USD | -3,457,000USD | -10,929,000USD | 1,214,000USD | 5,730,000USD | 6,108,000USD |
| Net Income From Continuing Ops | — | 24,288,000USD | 19,668,000USD | 35,149,000USD | 20,547,000USD | 30,746,000USD | 47,213,000USD | 35,488,000USD |
| Ebit | — | 9,910,000USD | 15,243,000USD | 31,692,000USD | 9,618,000USD | 31,960,000USD | 52,943,000USD | 41,596,000USD |
| Ebitda | — | 10,392,000USD | 15,720,000USD | 32,161,000USD | 10,080,000USD | 32,420,000USD | 53,442,000USD | 41,853,000USD |
| Depreciation And Amortization | — | 482,000USD | 477,000USD | 469,000USD | 462,000USD | 460,000USD | 499,000USD | 257,000USD |
| Reconciled Depreciation | — | 482,000USD | 477,000USD | 469,000USD | 462,000USD | 460,000USD | 499,000USD | 198,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 761,407,000USD | 482,375,000USD | 401,858,000USD | 365,978,000USD | 353,874,000USD | 306,486,000USD | 251,247,000USD | 159,201,000USD |
| Cost Of Revenue | 12,977,000USD | 6,481,000USD | 5,385,000USD | 5,281,000USD | 5,582,000USD | 5,504,000USD | 5,215,000USD | 3,554,000USD |
| Gross Profit | 748,430,000USD | 475,894,000USD | 396,473,000USD | 360,697,000USD | 348,292,000USD | 300,982,000USD | 246,032,000USD | 155,647,000USD |
| Research Development | 254,908,000USD | 184,353,000USD | 130,991,000USD | 113,864,000USD | 114,764,000USD | 89,017,000USD | 75,247,000USD | 40,376,000USD |
| Selling General Administrative | 448,725,000USD | 184,259,000USD | 152,848,000USD | 122,356,000USD | 105,326,000USD | 100,359,000USD | 81,289,000USD | 62,416,000USD |
| Total Operating Expenses | 703,633,000USD | 368,612,000USD | 283,839,000USD | 236,220,000USD | 220,090,000USD | 189,376,000USD | 156,536,000USD | 102,792,000USD |
| Operating Income | 44,797,000USD | 107,282,000USD | 112,634,000USD | 124,477,000USD | 128,202,000USD | 111,606,000USD | 89,496,000USD | 52,855,000USD |
| Interest Income | 21,666,000USD | 17,275,000USD | 3,557,000USD | 529,000USD | 3,400,000USD | 5,070,000USD | 2,657,000USD | 49,000USD |
| Net Interest Income | 21,666,000USD | 17,275,000USD | 3,557,000USD | 529,000USD | 3,400,000USD | 5,070,000USD | 2,657,000USD | -49,000USD |
| Income Before Tax | 66,462,999USD | 124,557,000USD | 116,191,000USD | 125,006,000USD | 131,602,000USD | 116,676,000USD | 92,153,000USD | 52,806,000USD |
| Income Tax Expense | -33,189,000USD | 18,417,000USD | 14,773,000USD | 12,494,000USD | 25,591,000USD | 22,495,000USD | 16,743,000USD | -76,316,000USD |
| Tax Provision | -33,189,000USD | 18,417,000USD | 14,773,000USD | 12,494,000USD | 25,591,000USD | 22,495,000USD | 16,743,000USD | -76,316,000USD |
| Net Income | 99,652,000USD | 106,140,000USD | 101,418,000USD | 112,512,000USD | 106,011,000USD | 94,181,000USD | 75,410,000USD | 129,122,000USD |
| Net Income From Continuing Ops | 99,652,000USD | 106,140,000USD | 101,418,000USD | 112,512,000USD | 106,011,000USD | 94,181,000USD | 75,410,000USD | 129,122,000USD |
| Ebit | 66,462,999USD | 124,557,000USD | 112,634,000USD | 124,477,000USD | 128,202,000USD | 111,606,000USD | 89,496,000USD | 52,855,000USD |
| Ebitda | 68,352,999USD | 125,599,000USD | 115,603,000USD | 127,544,000USD | 130,439,000USD | 113,777,000USD | 89,732,000USD | 52,961,000USD |
| Depreciation And Amortization | 1,890,000USD | 1,042,000USD | 2,969,000USD | 3,067,000USD | 2,237,000USD | 2,171,000USD | 236,000USD | 106,000USD |
| Reconciled Depreciation | 1,890,000USD | 2,362,000USD | 2,969,000USD | 3,067,000USD | 2,237,000USD | 2,171,000USD | 236,000USD | 106,000USD |
| Total Other Income Expense Net | 21,665,999USD | 17,275,000USD | 3,557,000USD | 529,000USD | 3,400,000USD | 5,070,000USD | 2,657,000USD | -49,000USD |
| Interest Expense | — | — | 3,557,000USD | 3,596,000USD | 5,637,000USD | 5,070,000USD | 2,657,000USD | 49,000USD |
| Net Income Applicable To Common Shares | — | — | 101,288,000USD | 112,512,000USD | 106,011,000USD | 94,181,000USD | 75,410,000USD | 129,122,000USD |
| Non Operating Income Net Other | — | — | — | 529,000USD | 3,400,000USD | 5,070,000USD | 2,657,000USD | -49,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 888,702,000USD | 814,881,000USD | 836,651,000USD | 823,607,000USD | 801,722,000USD | 846,455,000USD | 840,553,000USD | 784,257,000USD |
| Cash And Equivalents | 111,039,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 308,197,000USD | 338,184,000USD | 372,152,000USD | 421,683,000USD | 342,226,000USD | 322,763,000USD | 383,334,000USD | 380,336,000USD |
| Short Term Investments | 197,158,000USD | 229,446,000USD | 251,657,000USD | 296,545,000USD | 239,481,000USD | 232,944,000USD | 255,669,000USD | 243,047,000USD |
| Long Term Investments | 236,451,000USD | 177,261,000USD | 160,270,000USD | 102,557,000USD | 172,775,000USD | 248,041,000USD | 219,831,000USD | 167,310,000USD |
| Total Current Assets | 439,676,000USD | 426,033,000USD | 485,464,000USD | 541,130,000USD | 443,112,000USD | 438,503,000USD | 471,602,000USD | 466,978,000USD |
| Other Current Assets | 8,363,000USD | 35,887,000USD | 40,658,000USD | 33,569,000USD | 19,943,000USD | 16,953,000USD | 17,780,000USD | 15,975,000USD |
| Other Non Current Assets | 2,946,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 182,926,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 153,802,000USD | 149,185,000USD | 166,085,000USD | 172,265,000USD | 144,664,000USD | 143,066,000USD | 140,773,000USD | 126,216,000USD |
| Other Current Liabilities | 115,347,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 705,776,000USD | 637,987,000USD | 647,805,000USD | 631,902,000USD | 635,793,000USD | 683,285,000USD | 679,589,000USD | 638,835,000USD |
| Total Equity Including Noncontrolling Interest | 705,776,000USD | — | — | — | — | — | — | — |
| Net Receivables | 76,920,000USD | 39,072,000USD | 59,786,000USD | 73,529,000USD | 68,667,000USD | 84,419,000USD | 58,076,000USD | 62,617,000USD |
| Inventory | 13,185,000USD | 12,890,000USD | 12,868,000USD | 12,349,000USD | 12,276,000USD | 14,368,000USD | 12,412,000USD | 8,050,000USD |
| Property Plant Equipment Net | 11,993,000USD | 10,367,000USD | 6,473,000USD | 6,870,000USD | 7,312,000USD | 7,690,000USD | 8,013,000USD | 8,433,000USD |
| Accounts Payable | 14,910,000USD | 33,306,000USD | 40,444,000USD | 34,446,000USD | 23,525,000USD | 27,947,000USD | 15,376,000USD | 18,584,000USD |
| Short Term Debt | 1,917,000USD | 1,627,000USD | 1,084,000USD | 1,050,000USD | 1,016,999USD | 984,000USD | 829,000USD | 432,000USD |
| Common Stock | 142,000USD | 141,000USD | 140,000USD | 139,000USD | 138,000USD | 137,000USD | 136,000USD | 135,000USD |
| Retained Earnings | 654,613,000USD | 611,626,000USD | 643,387,000USD | 619,099,000USD | 599,431,000USD | 564,282,000USD | 543,735,000USD | 512,989,000USD |
| Accumulated Other Comprehensive Income | 436,000USD | 918,000USD | 2,264,000USD | 2,341,000USD | 2,291,000USD | 692,000USD | -217,000USD | 1,571,000USD |
| Total Liab | — | 176,894,000USD | 188,846,000USD | 191,705,000USD | 165,929,000USD | 163,170,000USD | 160,964,000USD | 145,422,000USD |
| Other Current Liab | — | 65,358,000USD | 73,702,000USD | 136,769,000USD | 120,122,000USD | 99,882,000USD | 124,377,000USD | 107,200,000USD |
| Capital Stock | — | 141,000USD | 140,000USD | 139,000USD | 138,000USD | 137,000USD | 136,000USD | 135,000USD |
| Cash | — | 108,738,000USD | 120,495,000USD | 125,138,000USD | 102,745,000USD | 89,819,000USD | 127,665,000USD | 137,289,000USD |
| Current Deferred Revenue | — | 33,562,000USD | 35,679,000USD | — | 50,866,000USD | — | 41,580,000USD | 38,799,000USD |
| Net Debt | — | -99,101,000USD | -114,388,000USD | -118,780,000USD | -96,140,000USD | -82,984,000USD | -120,729,000USD | -130,498,000USD |
| Short Long Term Debt Total | — | 9,637,000USD | 6,107,000USD | 6,358,000USD | 6,605,000USD | 6,835,000USD | 6,936,000USD | 6,791,000USD |
| Property Plant Equipment Gross | — | 10,367,000USD | 6,473,000USD | 6,870,000USD | 7,312,000USD | 7,690,000USD | 8,013,000USD | 8,433,000USD |
| Common Stock Shares Outstanding | — | 104,435,000shares | 119,855,000shares | 119,439,000shares | 120,485,000shares | 119,819,000shares | 118,459,000shares | 113,723,000shares |
| Non Current Assets Total | — | 388,848,000USD | 351,187,000USD | 282,477,000USD | 358,610,000USD | 407,952,000USD | 368,951,000USD | 317,279,000USD |
| Non Current Liabilities Total | — | 27,709,000USD | 22,761,000USD | 19,440,000USD | 21,265,000USD | 20,103,999USD | 20,191,000USD | 19,206,000USD |
| Non Currrent Assets Other | — | 19,659,000USD | 16,247,000USD | 20,051,000USD | 16,294,000USD | 7,776,000USD | 10,193,000USD | 14,737,000USD |
| Net Working Capital | — | 276,848,000USD | 319,379,000USD | 368,865,000USD | 298,448,000USD | 295,437,000USD | 330,829,000USD | 340,762,000USD |
| Unclassified Non Current Assets | — | 181,561,000USD | 168,197,000USD | 152,999,000USD | 162,229,000USD | 144,445,000USD | 130,914,000USD | 126,799,000USD |
| Unclassified Current Liabilities | — | 15,332,000USD | 15,176,000USD | — | -50,865,999USD | 14,253,000USD | -41,389,000USD | -38,799,000USD |
| Unclassified Non Current Liabilities | — | 27,709,000USD | 22,761,000USD | 19,440,000USD | 21,265,000USD | 20,103,999USD | 20,191,000USD | 19,206,000USD |
| Unclassified Equity | — | 25,161,000USD | — | 10,184,000USD | 33,795,000USD | 118,037,000USD | 135,799,000USD | 124,005,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 836,651,000USD | 840,553,000USD | 621,517,000USD | 583,430,000USD | 423,756,000USD | 571,731,000USD | 412,312,000USD | 311,694,000USD |
| Other Current Assets | 40,658,000USD | 17,780,000USD | 25,862,000USD | 14,624,000USD | 8,915,000USD | 6,697,000USD | 6,044,000USD | 7,740,000USD |
| Total Liab | 188,846,000USD | 160,964,000USD | 114,812,000USD | 81,588,000USD | 47,950,000USD | 48,393,000USD | 41,130,000USD | 35,812,000USD |
| Total Stockholder Equity | 647,805,000USD | 679,589,000USD | 506,705,000USD | 501,842,000USD | 375,806,000USD | 523,338,000USD | 371,182,000USD | 275,882,000USD |
| Other Current Liab | 73,702,000USD | 124,377,000USD | 84,066,000USD | 59,283,000USD | 39,594,000USD | -11,462,000USD | 29,274,000USD | 25,765,000USD |
| Common Stock | 140,000USD | 136,000USD | 133,000USD | 131,000USD | 127,000USD | 122,000USD | 120,000USD | 117,000USD |
| Capital Stock | 140,000USD | 136,000USD | 133,000USD | 131,000USD | 127,000USD | 122,000USD | 120,000USD | 117,000USD |
| Retained Earnings | 643,387,000USD | 543,735,000USD | 402,526,000USD | 296,386,000USD | 194,968,000USD | 82,456,000USD | -23,555,000USD | -117,736,000USD |
| Cash | 120,495,000USD | 127,665,000USD | 135,551,000USD | 66,329,000USD | 77,617,000USD | 476,892,000USD | 31,269,000USD | 206,760,000USD |
| Cash And Short Term Investments | 372,152,000USD | 383,334,000USD | 368,221,000USD | 431,672,000USD | 223,535,000USD | 476,892,000USD | 275,962,000USD | 206,760,000USD |
| Total Current Assets | 485,464,000USD | 471,602,000USD | 458,636,000USD | 499,253,000USD | 266,463,000USD | 524,247,000USD | 307,358,000USD | 240,590,000USD |
| Total Current Liabilities | 166,085,000USD | 140,773,000USD | 104,505,000USD | 72,491,000USD | 47,541,000USD | 10,554,000USD | 38,841,000USD | 35,812,000USD |
| Current Deferred Revenue | 35,679,000USD | — | 18,468,000USD | 11,098,000USD | 11,174,000USD | 9,412,000USD | 8,209,000USD | — |
| Net Debt | -114,388,000USD | -120,729,000USD | -135,400,000USD | -65,186,000USD | -77,091,000USD | -474,341,000USD | -27,808,000USD | -206,760,000USD |
| Short Term Debt | 1,084,000USD | 829,000USD | 151,000USD | 1,143,000USD | 526,000USD | 2,050,000USD | 1,558,000USD | — |
| Short Long Term Debt Total | 6,107,000USD | 6,936,000USD | 151,000USD | 1,143,000USD | 526,000USD | 2,551,000USD | 3,461,000USD | — |
| Long Term Investments | 160,270,000USD | 219,831,000USD | 57,176,000USD | 4,947,000USD | 112,277,000USD | 36,196,000USD | 39,352,000USD | 0USD |
| Short Term Investments | 251,657,000USD | 255,669,000USD | 232,670,000USD | 365,343,000USD | 145,918,000USD | 364,506,000USD | 244,693,000USD | 165,135,000USD |
| Net Receivables | 59,786,000USD | 58,076,000USD | 56,823,000USD | 46,857,000USD | 29,025,000USD | 26,198,000USD | 19,928,000USD | 17,588,000USD |
| Inventory | 12,868,000USD | 12,412,000USD | 7,730,000USD | 6,100,000USD | 4,988,000USD | 21,157,000USD | 5,424,000USD | 16,242,000USD |
| Accounts Payable | 40,444,000USD | 15,376,000USD | 17,396,000USD | 11,976,000USD | 6,908,000USD | 10,554,000USD | 7,537,000USD | 8,266,000USD |
| Property Plant Equipment Net | 6,473,000USD | 8,013,000USD | 315,000USD | 1,776,000USD | 1,516,000USD | 2,509,000USD | 4,496,000USD | 655,000USD |
| Property Plant Equipment Gross | 6,473,000USD | 8,013,000USD | 315,000USD | 1,143,000USD | 514,000USD | 4,184,000USD | 4,496,000USD | 655,000USD |
| Accumulated Other Comprehensive Income | 2,264,000USD | -217,000USD | 609,000USD | -869,000USD | -227,000USD | 415,000USD | 261,000USD | -70,000USD |
| Common Stock Shares Outstanding | 119,987,000shares | 113,480,000shares | 111,742,000shares | 115,966,000shares | 125,963,000shares | 124,194,000shares | 122,566,000shares | 126,688,000shares |
| Non Current Assets Total | 351,187,000USD | 368,951,000USD | 162,881,000USD | 84,177,000USD | 157,293,000USD | 47,484,000USD | 104,954,000USD | 71,104,000USD |
| Non Current Liabilities Total | 22,761,000USD | 20,191,000USD | 10,307,000USD | 9,097,000USD | 409,000USD | 37,839,000USD | 2,289,000USD | 239,000USD |
| Non Currrent Assets Other | 16,247,000USD | 10,193,000USD | 14,785,000USD | 15,989,000USD | 16,045,000USD | 13,372,000USD | 15,429,000USD | 7,790,000USD |
| Net Working Capital | 319,379,000USD | 330,829,000USD | 354,131,000USD | 426,762,000USD | 218,922,000USD | 431,007,000USD | 268,517,000USD | 201,247,000USD |
| Unclassified Non Current Assets | 168,197,000USD | 130,914,000USD | 90,605,000USD | -15,989,000USD | -16,045,000USD | -57,443,000USD | -15,429,000USD | -11,560,000USD |
| Unclassified Current Liabilities | 15,176,000USD | — | -15,576,000USD | -11,009,000USD | -10,661,000USD | -11,462,000USD | -7,737,000USD | 1,781,000USD |
| Unclassified Non Current Liabilities | 22,761,000USD | 20,191,000USD | 10,307,000USD | — | — | 36,542,000USD | — | — |
| Unclassified Equity | — | 135,799,000USD | 103,304,000USD | 206,063,000USD | 180,811,000USD | 440,223,000USD | 456,940,000USD | 417,111,000USD |
| Other Liab | — | — | — | 9,097,000USD | 409,000USD | 398,000USD | 386,000USD | 239,000USD |
| Other Assets | — | — | — | 77,454,000USD | 43,500,000USD | 52,850,000USD | 61,106,000USD | 74,219,000USD |
| Net Tangible Assets | — | — | — | 501,842,000USD | 375,806,000USD | 523,338,000USD | 371,182,000USD | 275,882,000USD |
| Non Current Liabilities Other | — | — | — | — | 409,000USD | 899,000USD | 2,289,000USD | 239,000USD |
| Unclassified Current Assets | — | — | — | — | — | -371,203,000USD | — | -172,875,000USD |
| Treasury Stock | — | — | — | — | — | — | -62,704,000USD | -23,657,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 1,461,000USD |
| Stock Based Compensation | 52,459,000USD |
| Deferred Income Tax | -10,229,000USD |
| Change To Account Receivables | -17,134,000USD |
| Change To Inventory | -7,536,000USD |
| Change To Liabilities | -25,885,000USD |
| Change In Working Capital | -49,215,000USD |
| Operating Cash Flow | 16,771,000USD |
| Capital Expenditures | -2,729,000USD |
| Net Investments | -21,971,000USD |
| Investing Cash Flow | -24,700,000USD |
| Common Stock Issuance | 6,200,000USD |
| Net Common Stock Issuance | -17,218,000USD |
| Unclassified Financing Cash Flow | 9,741,000USD |
| Financing Cash Flow | -1,277,000USD |
| Effect Of Forex Changes On Cash | -250,000USD |
| Change In Cash | -9,456,000USD |
| End Cash Flow | 112,289,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -31,761,000USD | 19,359,000USD | 35,149,000USD | 20,547,000USD | 30,389,000USD | 46,690,000USD | 35,120,000USD | 27,762,000USD |
| Depreciation | 598,000USD | 477,000USD | 469,000USD | 462,000USD | 460,000USD | 499,000USD | 257,000USD | 179,000USD |
| Stock Based Compensation | 23,043,000USD | 22,879,000USD | 19,023,000USD | 21,830,000USD | 16,796,000USD | 16,102,000USD | 15,207,000USD | 13,249,000USD |
| Other Non Cash Items | -3,952,000USD | 22,183,000USD | -1,312,000USD | -1,693,000USD | -1,834,000USD | 13,759,000USD | 12,494,000USD | -2,859,000USD |
| Change To Account Receivables | 20,714,000USD | -5,062,000USD | -2,748,000USD | -7,843,000USD | 5,741,000USD | -5,880,000USD | 7,681,000USD | -6,395,000USD |
| Change To Inventory | -3,272,000USD | -3,943,000USD | -4,626,000USD | 605,000USD | -78,000USD | 1,081,000USD | -1,681,000USD | 983,000USD |
| Change In Working Capital | 8,410,000USD | 3,348,000USD | 8,374,000USD | -22,313,000USD | 17,347,000USD | 28,088,000USD | 7,275,000USD | -7,413,000USD |
| Total Cash From Operating Activities | -16,772,000USD | 54,481,000USD | 43,939,000USD | 5,128,000USD | 59,300,000USD | 73,829,000USD | 41,182,000USD | 23,756,000USD |
| Capital Expenditures | -201,000USD | 0USD | -57,000USD | -104,000USD | -121,000USD | -1,635,000USD | -416,000USD | 0USD |
| Free Cash Flow | -16,973,000USD | 54,481,000USD | 43,882,000USD | 5,024,000USD | 59,179,000USD | 72,194,000USD | 40,766,000USD | 23,756,000USD |
| Investments | 4,743,000USD | 14,645,000USD | 70,127,000USD | -3,171,000USD | -64,360,000USD | -44,036,000USD | -60,194,000USD | -9,014,000USD |
| Total Cashflows From Investing Activities | 4,542,000USD | 14,645,000USD | 70,127,000USD | -3,171,000USD | -64,360,000USD | -44,036,000USD | -60,194,000USD | -9,014,000USD |
| Total Cash From Financing Activities | 760,000USD | -46,413,000USD | -102,934,000USD | -39,803,000USD | -4,564,000USD | -21,092,000USD | -2,150,000USD | -543,000USD |
| Sale Purchase Of Stock | -5,761,000USD | -42,464,000USD | -103,018,000USD | -27,433,000USD | 0USD | -11,710,000USD | -3,478,000USD | -476,000USD |
| Change In Cash | -11,757,000USD | 22,393,000USD | 12,926,000USD | -37,846,000USD | -9,624,000USD | 8,701,000USD | -21,162,000USD | 14,199,000USD |
| Begin Period Cash Flow | 121,745,000USD | 102,745,000USD | 89,819,000USD | 127,665,000USD | 137,289,000USD | 128,588,000USD | 149,750,000USD | 135,551,000USD |
| End Period Cash Flow | 109,988,000USD | 125,138,000USD | 102,745,000USD | 89,819,000USD | 127,665,000USD | 137,289,000USD | 128,588,000USD | 149,750,000USD |
| Other Cashflows From Financing Activities | 10,000USD | -8,152,000USD | -12,426,000USD | -39,803,000USD | -4,564,000USD | -11,651,000USD | -1,909,000USD | -543,000USD |
| Unclassified Operating Cash Flow | -13,110,000USD | -13,765,000USD | -17,764,000USD | -13,705,000USD | -3,858,000USD | -31,309,000USD | -29,171,000USD | -7,162,000USD |
| Unclassified Financing Cash Flow | 6,511,000USD | 4,203,000USD | 12,510,000USD | 27,433,000USD | — | 2,269,000USD | 3,237,000USD | — |
| Unclassified Investing Cash Flow | — | — | — | — | — | 1,635,000USD | 60,194,000USD | 9,014,000USD |
| Other Cashflows From Investing Activities | — | — | — | — | — | — | -59,778,000USD | -9,014,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 141,209,000USD | 106,140,000USD | 101,418,000USD | 112,512,000USD | 106,011,000USD | 94,181,000USD | 75,410,000USD | 129,122,000USD |
| Depreciation | 1,336,000USD | 2,362,000USD | 3,446,000USD | 3,067,000USD | 2,237,000USD | 2,171,000USD | 236,000USD | 106,000USD |
| Stock Based Compensation | 61,354,000USD | 48,940,000USD | 42,442,000USD | 42,931,000USD | 33,539,000USD | 29,313,000USD | 23,747,000USD | 13,361,000USD |
| Other Non Cash Items | -10,938,000USD | -9,128,000USD | 1,383,000USD | 5,093,000USD | 1,451,000USD | -1,738,000USD | -1,721,000USD | 763,000USD |
| Change To Account Receivables | 1,147,000USD | -10,066,000USD | -17,432,000USD | -1,427,000USD | -6,270,000USD | -2,340,000USD | -2,288,000USD | -5,440,000USD |
| Change To Inventory | 305,000USD | 1,265,000USD | 1,199,000USD | 3,444,000USD | -3,514,000USD | -1,044,000USD | -7,779,000USD | -2,262,000USD |
| Change In Working Capital | 45,297,000USD | 8,218,000USD | 5,539,000USD | -57,000USD | -5,357,000USD | -4,687,000USD | 3,926,000USD | -5,714,000USD |
| Total Cash From Operating Activities | 198,067,000USD | 127,039,000USD | 120,323,000USD | 167,892,000USD | 151,970,000USD | 136,117,000USD | 115,665,000USD | 60,935,000USD |
| Capital Expenditures | -2,172,000USD | -139,000USD | -413,000USD | -469,000USD | -1,238,000USD | -1,088,000USD | -298,000USD | -419,000USD |
| Free Cash Flow | 195,895,000USD | 126,900,000USD | 119,910,000USD | 167,423,000USD | 150,732,000USD | 135,029,000USD | 115,367,000USD | 60,516,000USD |
| Investments | -177,604,000USD | 56,567,000USD | -114,327,000USD | 136,595,000USD | -118,025,000USD | -116,740,000USD | -90,469,000USD | -73,037,000USD |
| Total Cashflows From Investing Activities | -177,604,000USD | 90,906,000USD | -114,327,000USD | 136,126,000USD | -119,263,000USD | -117,828,000USD | -90,767,000USD | -73,456,000USD |
| Total Cash From Financing Activities | -28,349,000USD | -148,723,000USD | -17,284,000USD | -302,591,000USD | 12,214,000USD | -28,645,000USD | -14,335,000USD | -7,953,000USD |
| Sale Purchase Of Stock | -15,664,000USD | -145,428,000USD | -21,665,000USD | -295,985,000USD | -9,945,000USD | -30,975,000USD | -23,657,000USD | 7,181,000USD |
| Change In Cash | -7,886,000USD | 69,222,000USD | -11,288,000USD | 1,427,000USD | 44,921,000USD | -10,356,000USD | 10,563,000USD | -20,474,000USD |
| Begin Period Cash Flow | 135,551,000USD | 66,329,000USD | 77,617,000USD | 76,190,000USD | 31,269,000USD | 41,625,000USD | 31,062,000USD | 51,536,000USD |
| End Period Cash Flow | 127,665,000USD | 135,551,000USD | 66,329,000USD | 77,617,000USD | 76,190,000USD | 31,269,000USD | 41,625,000USD | 31,062,000USD |
| Other Cashflows From Financing Activities | -22,301,000USD | -3,295,000USD | -17,284,000USD | -6,606,000USD | 22,159,000USD | 2,330,000USD | 9,322,000USD | 7,181,000USD |
| Unclassified Operating Cash Flow | -40,191,000USD | -29,493,000USD | -33,905,000USD | 4,346,000USD | 14,089,000USD | 16,877,000USD | 14,067,000USD | -76,703,000USD |
| Unclassified Investing Cash Flow | 2,172,000USD | 34,478,000USD | 114,327,000USD | -136,595,000USD | — | 116,740,000USD | 90,469,000USD | 73,037,000USD |
| Unclassified Financing Cash Flow | 9,616,000USD | — | 45,529,000USD | 14,204,000USD | 21,541,000USD | 6,967,000USD | — | -7,181,000USD |
| Change To Liabilities | — | — | 4,757,000USD | 1,631,000USD | 8,317,000USD | 1,851,000USD | 6,168,000USD | 15,615,000USD |
| Dividends Paid | — | — | -23,864,000USD | -14,204,000USD | -21,541,000USD | -6,967,000USD | — | 0USD |
| Other Cashflows From Investing Activities | — | — | -113,914,000USD | 136,595,000USD | — | -116,740,000USD | -90,469,000USD | -73,037,000USD |
| Cash And Cash Equivalents Changes | — | — | — | 1,427,000USD | 44,921,000USD | -10,356,000USD | 10,563,000USD | -20,474,000USD |
| Net Borrowings | — | — | — | — | — | — | — | -15,134,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Product | Hypercortisolism Products | 208,583,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Lifyorli | 47,564,000 | USD | Disclosure |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.